172 related articles for article (PubMed ID: 32481447)
21. Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis.
Miao C; Liang C; Zhu J; Xu A; Zhao K; Hua Y; Zhang J; Chen W; Suo C; Zhang C; Liu Y; Su S; Wang Z
Oncotarget; 2017 May; 8(19):32309-32321. PubMed ID: 28427222
[TBL] [Abstract][Full Text] [Related]
22. Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer.
Peng C; Wallwiener M; Rudolph A; Ćuk K; Eilber U; Celik M; Modugno C; Trumpp A; Heil J; Marmé F; Madhavan D; Nees J; Riethdorf S; Schott S; Sohn C; Pantel K; Schneeweiss A; Chang-Claude J; Yang R; Burwinkel B
Int J Cancer; 2016 May; 138(10):2499-509. PubMed ID: 26686298
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.
Sun X; Zhangyuan G; Shi L; Wang Y; Sun B; Ding Q
Medicine (Baltimore); 2017 May; 96(19):e6860. PubMed ID: 28489780
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value and clinicopathologic significance of nm23 in various cancers: A systematic review and meta-analysis.
Liu L; Li M; Zhang C; Zhang J; Li G; Zhang Z; He X; Fan M
Int J Surg; 2018 Dec; 60():257-265. PubMed ID: 30389538
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
Zhang G; Cai J
J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
Petrelli F; Viale G; Cabiddu M; Barni S
Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis.
Xu H; Liu Z; Shi H; Wang C
BMC Cancer; 2020 Nov; 20(1):1051. PubMed ID: 33131491
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor 1α in breast cancer prognosis.
Wang W; He YF; Sun QK; Wang Y; Han XH; Peng DF; Yao YW; Ji CS; Hu B
Clin Chim Acta; 2014 Jan; 428():32-7. PubMed ID: 24482805
[TBL] [Abstract][Full Text] [Related]
32. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
33. Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers.
Zhang T; Wu DM; Deng SH; Han R; Liu T; Li J; Xu Y
Cell Physiol Biochem; 2018; 49(2):530-544. PubMed ID: 30157490
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and clinicopathological value of NM23 expression in patients with breast cancer: A systematic review and meta-analysis.
Han W; Zhang C; Cao FY; Cao F; Jiang L; Ding HZ
Curr Probl Cancer; 2017; 41(1):80-93. PubMed ID: 28161101
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis.
Sabapathi N; Sabarimurugan S; Madurantakam Royam M; Kumarasamy C; Xu X; Xu G; Jayaraj R
Mol Diagn Ther; 2019 Dec; 23(6):695-706. PubMed ID: 31372939
[TBL] [Abstract][Full Text] [Related]
36. Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients.
Wan G; Xiang L; Sun X; Wang X; Li H; Ge W; Cao F
Oncotarget; 2017 Jan; 8(3):5382-5391. PubMed ID: 28036271
[TBL] [Abstract][Full Text] [Related]
37. The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature.
Zhao S; Liu Y; Zhang Q; Li H; Zhang M; Ma W; Zhao W; Wang J; Yang M
Breast Cancer Res Treat; 2011 Dec; 130(3):809-16. PubMed ID: 21311967
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological and prognostic role of SIRT1 in breast cancer patients: a meta-analysis.
Cao YW; Li YC; Wan GX; Du XM; Li F
Int J Clin Exp Med; 2015; 8(1):616-24. PubMed ID: 25785036
[TBL] [Abstract][Full Text] [Related]
40. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]